Overview
Top-down proteomics analyzes intact proteins by mass spectrometry without prior enzymatic digestion. Unlike the conventional bottom-up approach that infers protein identities from peptides, top-down proteomics measures the intact mass of a protein and subsequently fragments it inside the mass spectrometer to obtain sequence information. This approach preserves the complete protein context, meaning that combinations of post-translational modifications, sequence variants, and alternative splice forms — collectively termed proteoforms — are observed as distinct molecular species. Top-down proteomics therefore provides a direct and unambiguous view of the proteoform landscape that is largely invisible to bottom-up methods.
Methods
Intact protein ions are introduced into the mass spectrometer via electrospray ionization, which generates a charge-state envelope from which the molecular mass is calculated. Fragmentation is achieved using techniques such as electron capture dissociation (ECD) or electron transfer dissociation (ETD), which preferentially cleave the protein backbone while preserving labile modifications like phosphorylation and glycosylation. Proteoform identification relies on algorithms that match the measured intact mass and fragment ions against a database of predicted proteoforms. Ultra-high-resolution mass spectrometers such as Fourier-transform ion cyclotron resonance (FT-ICR) and Orbitrap instruments are essential for resolving the small mass differences between related proteoforms.
Applications
Top-down proteomics excels at characterizing post-translational modifications and their combinatorial patterns on individual proteins. It is used to study histone modification codes, antibody heterogeneity, and protein degradation products. The approach complements bottom-up proteomics and mass spectrometry and benefits from the same mass spectrometry instrumentation, while providing unique insights into proteoform biology that are critical for understanding disease mechanisms and developing precision therapies.